The vast amount of information producednby genomics and proteomics studies isngenerating more potential drug targetsnthan ever before. But translating thesentargets into successful drug candidatesnstill represents a huge challenge, and thennumber of new drugs reachingnmarket is failing to show a cor-nresponding increase. One pow-nerful approach to convertingntarget information into new ther-napeutic entities involves the usenof diverse compound libraries.nLibraries of proteins or peptidesncontain molecules akin to naturalnmodulators of cellular processesnand therefore represent obviousndrug candidates.
展开▼
